Mynx Ace™ Vascular Closure Device Leaves No Implant Behind

AccessClosure Inc., has commercially launched its Mynx Ace Vascular Closure Device at ACC 2014. The company says the device is a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites.

ACIST’s Rapid FFR System Launched at ACC 2014

Following FDA clearance in January, ACIST Medical Systems, Inc., has now announced the global introduction of the new ACIST|RXi™ Rapid Exchange FFR System – the world’s first Rapid Exchange FFR system. This device features new technology designed to provide physicians with a fast and easy way to perform Fractional Flow Reserve (FFR) procedures.

FDA Approves Abbott’s Supera® Stent to Treat People with Peripheral Artery Disease

Abbott’s Supera® Peripheral Stent System has received U.S. FDA approval to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD). PAD occurs when fat and cholesterol buildup causes arteries outside of the heart to narrow, which reduces blood flow to parts of the body, most commonly the legs. The disease affects 12 to 20 percent of Americans age 65 or older and can cause leg pain, in addition to increasing the risk of heart attack or stroke.

ScanMed Introduces New Orbit and Mandible Array to the MRI Market

MRI technology specialist, ScanMed of Resonance Innovations LLC, will be introducing its new Orbit and Mandible Array and Targeting System at this year’s AAPOS (American Association for Pediatric Ophthalmology and Strabismus) Annual Meeting in Palm Springs from April 2-6, 2014.

FDA Clears Next Generation Medigus Muse™ System for GERD Threatment

Israeli medical device company Medigus Ltd. has gained U.S. FDA 510(k) clearance for its next generation MUSE™ system, formerly known as the SRS™ system. Muse is a device which enables an incisionless procedure by performing an anterior partial fundoplication with standard surgical staples in a less invasive way.

FDA Approves St. Jude’s Allure Quadra™, Assurity™ and Endurity™ Devices

St. Jude Medical, Inc. has announced approval from the U.S. FDA for the Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P), which provides additional pacing innovations for physicians to treat patients with heart failure. The company also announced FDA approvals for the Assurity™ pacemaker and Endurity™ pacemaker families of devices.

CE Mark and EU Launch for St. Jude’s Prodigy Spinal Cord Stimulation System with Burst Technology

St. Jude Medical, Inc. has seen its Prodigy™ Chronic Pain System with Burst Technology gain CE Mark approval, which it says will be followed by European launch.

Most read

Latest

^